Switch theme
Sign up to access all valuation multiples
Europlasma SA offers hazardous and non-hazardous waste management solutions. The company specializes in waste vitrification and develops equipment used in plasma-arc treatment which produces glass-like, leach-resistant slag.
1992
116
Last FY Revenue $50.0M
Last FY EBITDA -$3.0M
$22.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Europlasma achieved revenue of $50.0M and an EBITDA of -$3.0M.
Europlasma expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Europlasma valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $50.0M | XXX | XXX | XXX |
| Gross Profit | XXX | $26.7M | XXX | XXX | XXX |
| Gross Margin | XXX | 53% | XXX | XXX | XXX |
| EBITDA | XXX | -$3.0M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -6% | XXX | XXX | XXX |
| EBIT | XXX | -$30.7M | XXX | XXX | XXX |
| EBIT Margin | XXX | -62% | XXX | XXX | XXX |
| Net Profit | XXX | -$18.0M | XXX | XXX | XXX |
| Net Margin | XXX | -36% | XXX | XXX | XXX |
| Net Debt | XXX | $14.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 4, 2025, Europlasma's stock price is EUR 0 (or $0).
Europlasma has current market cap of EUR 7.1M (or $8.3M), and EV of EUR 19.0M (or $22.4M).
See Europlasma trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $22.4M | $8.3M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 4, 2025, Europlasma has market cap of $8.3M and EV of $22.4M.
Europlasma's trades at 0.4x EV/Revenue multiple, and -7.6x EV/EBITDA.
Equity research analysts estimate Europlasma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Europlasma's P/E ratio is not available.
See valuation multiples for Europlasma and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8.3M | XXX | $8.3M | XXX | XXX | XXX |
| EV (current) | $22.4M | XXX | $22.4M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -7.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -0.7x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -0.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -1.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEuroplasma's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.5M for the same period.
Europlasma's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Europlasma's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Europlasma and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -6% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 115% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Arcadis | XXX | XXX | XXX | XXX | XXX | XXX |
| Envipco | XXX | XXX | XXX | XXX | XXX | XXX |
| Cleanaway | XXX | XXX | XXX | XXX | XXX | XXX |
| The Environmental Group | XXX | XXX | XXX | XXX | XXX | XXX |
| EnviroSuite | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Europlasma acquired XXX companies to date.
Last acquisition by Europlasma was XXXXXXXX, XXXXX XXXXX XXXXXX . Europlasma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Europlasma founded? | Europlasma was founded in 1992. |
| Where is Europlasma headquartered? | Europlasma is headquartered in France. |
| How many employees does Europlasma have? | As of today, Europlasma has 116 employees. |
| Is Europlasma publicy listed? | Yes, Europlasma is a public company listed on PAR. |
| What is the stock symbol of Europlasma? | Europlasma trades under ALEUP ticker. |
| When did Europlasma go public? | Europlasma went public in 2009. |
| Who are competitors of Europlasma? | Similar companies to Europlasma include e.g. Arcadis, Envipco, Cleanaway, The Environmental Group. |
| What is the current market cap of Europlasma? | Europlasma's current market cap is $8.3M |
| Is Europlasma profitable? | Yes, Europlasma is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
